Open access · OA
via OpenAlex
Intramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy
Adam Williams, Barry Trachtenberg, Darcy L. Velazquez, Ian McNiece, Peter Altman, Didier Rouy, Adam Mendizabal, Pradip M. Pattany, Gustavo A. Lopera, Joel E. Fishman, Juan P. Zambrano, Alan W. Heldman, Joshua M. Hare
Circulation Research · 2011 · ▲ 317 citations
Abstract
RATIONALE: Transcatheter, intramyocardial injections of bone marrow-derived cell therapy produces reverse remodeling in large animal models of ischemic cardiomyopathy. OBJECTIVE: We used cardiac MRI (CMR) in patients with left ventricular (LV) dysfunction related to remote myocardial infarction (MI) to test the hypothesis that bone marrow progenitor cell injection causes functional recovery of scarred myocardium and reverse remodeling. METHODS AND RESULTS: Eight patients (aged 57.2±13.3 years) received transendocardial, intramyocardial injection of autologous bone marrow progenitor cells (mononuclear or mesenchymal stem cells) in LV scar and border zone. All patients tolerated the procedure with no serious adverse events. CMR at 1 year demonstrated a decrease in end diastolic volume (208.7±20.4 versus 167.4±7.32 mL; P=0.03), a trend toward decreased end systolic volume (142.4±16.5 versus 107.6±7.4 mL; P=0.06), decreased infarct size (P<0.05), and improved regional LV function by peak Eulerian circumferential strain in the treated infarct zone (-8.1±1.0 versus -11.4±1.3; P=0.04). Improvements in regional function were evident at 3 months, whereas the changes in chamber dimensions were not significant until 6 months. Improved regional function in the infarct zone strongly correlated with reduction of end diastolic volume (r(2)=0.69, P=0.04) and end systolic volume (r(2)=0.83, P=0.01). CONCLUSIONS: These data suggest that transcatheter, intramyocardial injections of autologous bone marrow progenitor cells improve regional contractility of a chronic myocardial scar, and these changes predict subsequent reverse remodeling. The findings support the potential clinical benefits of this new treatment strategy and ongoing randomized clinical trials.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1161/circresaha.111.242610
- Canonical
- link ↗
- Fetched
- 2026-08-28 MST
Cite this
APA
Williams, A., Trachtenberg, B., Velazquez, D.L., McNiece, I., Altman, P., Rouy, D., Mendizabal, A., Pattany, P.M., Lopera, G.A., Fishman, J.E., Zambrano, J.P., Heldman, A.W., & Hare, J.M. (2011). Intramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy. <em>Circulation Research</em>. https://doi.org/10.1161/circresaha.111.242610
Vancouver
Williams A, Trachtenberg B, Velazquez DL, McNiece I, Altman P, Rouy D, et al. Intramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy. Circulation Research. 2011. doi:10.1161/circresaha.111.242610.
BibTeX
@article{adam2011Intram,
title = {Intramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy},
author = {Adam Williams and Barry Trachtenberg and Darcy L. Velazquez and Ian McNiece and Peter Altman and Didier Rouy and Adam Mendizabal and Pradip M. Pattany and Gustavo A. Lopera and Joel E. Fishman and Juan P. Zambrano and Alan W. Heldman and Joshua M. Hare},
journal = {Circulation Research},
year = {2011},
doi = {10.1161/circresaha.111.242610},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Circulation 2004
Open access · OA
Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart Disease
Circulation 2014
Citation only
Abstract 19177: Effect of Aging on Human Mesenchymal Stem Cell Therapy in Ischemic Cardiomyopathy Patients
Cells 2021
Open access · CC-BY
Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials
Simpósio Internacional de Neurociências da Grande Dourados 2015
Citation only
THERAPY WITH MESENCHYMAL STEM CELLS IN AMYOTROPHIC LATERAL SCLEROSIS
Brain 2020
Citation only
Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis
International Journal of Molecular Sciences 2021
Open access · CC-BY